ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Return on Capital Employed [ROCE] (2023 - 2025)

Updated

ZyVersa Therapeutics (ZVSA) reported Return on Capital Employed [ROCE] of -101.59% for Q2 2025, up 110.59 percentage points from -212.18% a year earlier but down 5.39 percentage points from the prior quarter.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Return on Capital Employed [ROCE] (2023 - 2025) Analysis & Trends

For FY2024, ZyVersa Therapeutics posted Return on Capital Employed [ROCE] of -90.24%.

  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -861.71% in Q1 2024 and a high of -96.20% in Q1 2025.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last four quarters, with an average year-over-year change of +301.86 percentage points over the last five quarters.
  • Per Business Quant data, the three quarters before Q2 2025 came in at -96.20% (Q1 2025), -104.06% (Q4 2024) and -275.59% (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -101.59%
Mar 31, 2025 -96.20%
Dec 31, 2024 -104.06%
Sep 30, 2024 -275.59%
Jun 30, 2024 -212.18%
Mar 31, 2024 -861.71%
Dec 31, 2023 -623.28%
Sep 30, 2023 -455.37%
Jun 30, 2023 -146.41%
API Access

ZyVersa Therapeutics, Inc. Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ZVSA&period=max&api_key=YOUR_API_KEY